How to buy BIOLASE shares | $0.7721

Own BIOLASE shares in just a few minutes. Share price changes are updated daily.

BIOLASE, Inc (BIOL) is a leading medical devices business based in the US. On 11 June BIOLASE shares leapt 16.22% to a closing position of $0.8353. Over the last 12 months, BIOLASE's share price has risen by an impressive 86.00% from $0.4151. BIOLASE is listed on the NASDAQ and employs 135 staff. All prices are listed in US Dollars.

How has coronavirus impacted BIOLASE's share price?

Since the stock market crash that started in February 2020, BIOLASE's share price has had significant negative movement.

Its last market close was $0.73, which is 5.57% down on its pre-crash value of $0.7731 and 97.30% up on the lowest point reached during the March 2020 crash when the shares fell as low as $0.37.

If you had bought $1,000 worth of BIOLASE shares at the start of February 2020, those shares would have been worth $746.29 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,177.42.

BIOLASE share price

Use our graph to track the performance of BIOL stocks over time.

BIOLASE shares at a glance

Information last updated 2021-06-16.
Open$0.75
High$0.7775
Low$0.7405
Close$0.7721
Previous close$0.753
Change $0.0191
Change % 2.5365%
Volume 1,502,052
Information last updated 2021-06-10.
52-week range$0.245 - $1.51
50-day moving average $0.7106
200-day moving average $0.7679
Wall St. target price$2
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.977
Promoted
eToro Free Stocks

Invest in BIOLASE shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Name Product Ratings Finder rating Customer rating Min. initial deposit Price per trade Frequent trader rate Platform fee Offer Link
Hargreaves Lansdown Fund and Share Account
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£1
£11.95
£5.95
£0

Capital at risk

Platform details
FREE TRADES
eToro Free Stocks
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
$200
£0
N/A
£0

Capital at risk

Platform details
FREE TRADES
Stake
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£50
US: £0
N/A
£0
Join and receive a free share worth up to £100

Capital at risk

Platform details
Degiro Share Dealing
Finder score
★★★★★
★★★★★
Expert analysis
Not yet rated
£0.01
UK: £1.75 + 0.014% (max £5)
US: €0.50 + $0.004 per share
N/A
£0

Capital at risk

Platform details
interactive investor Trading Account
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£0
£7.99 (with one free trade per month)
N/A
£9.99 per month

Capital at risk

Platform details
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy BIOLASE stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

BIOLASE price performance over time

Historical closes compared with the last close of $0.7721

1 month (2021-05-14) 10.30%
3 months (2021-03-16) -17.86%
6 months (2020-12-16) 174.28%
1 year (2020-06-16) 46.90%
2 years (2019-06-14) -51.74%
3 years (2018-06-15) -38.23%
5 years (2016-06-16) -87.02%

Financials

Revenue TTM $26.1 million
Gross profit TTM $6.2 million
Return on assets TTM -27.33%
Return on equity TTM -108.65%
Profit margin -67.87%
Book value $0.224
Market capitalisation $112.3 million

TTM: trailing 12 months

How to short and sell BIOLASE shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "BIOL.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 6.2 million BIOLASE shares held short by investors – that's known as the "short interest". This figure is 3.5% up from 6.0 million last month.

There are a few different ways that this level of interest in shorting BIOLASE shares can be evaluated.

Short interest ratio (SIR)

BIOLASE's "short interest ratio" (SIR) is the quantity of BIOLASE shares currently shorted divided by the average quantity of BIOLASE shares traded daily (recently around 3.8 million). BIOLASE's SIR currently stands at 1.64. In other words for every 100,000 BIOLASE shares traded daily on the market, roughly 1640 shares are currently held short.

However BIOLASE's short interest can also be evaluated against the total number of BIOLASE shares, or, against the total number of tradable BIOLASE shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BIOLASE's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 BIOLASE shares in existence, roughly 40 shares are currently held short) or 0.0419% of the tradable shares (for every 100,000 tradable BIOLASE shares, roughly 42 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BIOLASE.

Find out more about how you can short BIOLASE stock.

BIOLASE share dividends

We're not expecting BIOLASE to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have BIOLASE's shares ever split?

BIOLASE's shares were split on a 1:5 basis on 11 May 2018. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BIOLASE shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for BIOLASE shares which in turn could have impacted BIOLASE's share price.

Share price volatility

Over the last 12 months, BIOLASE's shares have ranged in value from as little as $0.245 up to $1.51. A popular way to gauge a stock's volatility is its "beta".

BIOL.US volatility(beta: 1.45)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BIOLASE's is 1.4511. This would suggest that BIOLASE's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site